OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in de: Adding German translations) |
(Changed label, description and/or aliases in nl: Adding Dutch translations) |
||
label / nl | label / nl | ||
OncoTarvo.: Technologische innovatie geoptimaliseerd voor personalisatie van oncologische therapie |
Revision as of 18:15, 18 December 2021
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
349,140.0 Euro
0 references
467,816.0 Euro
0 references
74.63 percent
0 references
1 March 2016
0 references
1 March 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references